Structures by: Edler K. L.
Total: 7
Bis(3,5-dimethyl-1<i>H</i>-pyrazole-κ<i>N</i>^2^)silver(I) hexafluoridoantimonate
C10H16Ag1N4,F6Sb1
Acta Crystallographica Section E (2011) 67, 4 m496
a=7.0242(7)Å b=10.9849(11)Å c=21.391(2)Å
α=90° β=91.560(2)° γ=90°
(5<i>S</i>,6<i>R</i>)-5-Methyl-6-phenyl-4-propyl-1,3,4-oxadiazinane-2-thione
C13H18N2O1S1
Acta Crystallographica Section E (2009) 65, 6 o1421-o1422
a=12.5888(6)Å b=8.0648(4)Å c=14.2862(7)Å
α=90° β=112.4488(7)° γ=90°
(5<i>R</i>,6<i>S</i>)-4-Isopropyl-5-methyl-6-phenyl-3-propanoyl-2<i>H</i>- 1,3,4-oxadiazinan-2-one
C16H22N2O3
Acta Crystallographica Section E (2009) 65, 7 o1685-o1686
a=6.8644(3)Å b=10.8370(5)Å c=21.2348(10)Å
α=90° β=90° γ=90°
(6<i>S</i>)-2,4-Di-<i>tert</i>-butyl-6-[(4<i>S/i>,5<i>R</i>)- 3-isopropyl-4-methyl-5-phenyloxazolidin-2-yl]phenol
C27H39N1O2
Acta Crystallographica Section E (2010) 66, 4 o900-o901
a=18.9564(19)Å b=6.9943(7)Å c=18.3388(19)Å
α=90° β=91.833(2)° γ=90°
(6<i>R</i>)-2-<i>tert</i>-Butyl-6-[(4<i>R</i>,5<i>S</i>)-3-isopropyl-4-methyl- 5-phenyloxazolidin-2-yl]phenol
C23H31N1O2
Acta Crystallographica Section E (2010) 66, 4 o898-o899
a=9.5077(6)Å b=7.3257(5)Å c=14.9830(10)Å
α=90° β=101.6150(10)° γ=90°
(6<i>S</i>)-2-<i>tert</i>-Butyl-6-[(4<i>S/i>,5<i>R</i>)-3,4-dimethyl- 5-phenyloxazolidin-2-yl]phenol
C21H27N1O2
Acta Crystallographica Section E (2010) 66, 4 o902-o903
a=8.3288(8)Å b=9.8657(9)Å c=11.4325(11)Å
α=90° β=91.6670(10)° γ=90°
(5<i>S</i>)-4-(2,2-Dimethylpropyl)-5-isopropyl-1,3,4-oxadiazinan-2-one
C11H22N2O2
Acta Crystallographica Section E (2010) 66, 12 o3329-o3330
a=17.0330(18)Å b=11.2270(12)Å c=17.404(2)Å
α=90° β=100.073(2)° γ=90°